XELODA

Brand name authorized in: Austria Brazil Canada Cyprus Germany Spain Finland France Hong Kong Ireland Italy Lithuania Netherlands Poland Singapore Tunisia United States

Active ingredients

The drug XELODA contains one active pharmaceutical ingredient (API):

1 Capecitabine
UNII 6804DJ8Z9U - CAPECITABINE

Capecitabine is a non-cytotoxic fluoropyrimidine carbamate, which functions as an orally administered precursor of the cytotoxic moiety 5-fluorouracil (5-FU). There is evidence that the metabolism of 5-FU in the anabolic pathway blocks the methylation reaction of deoxyuridylic acid to thymidylic acid, thereby interfering with the synthesis of deoxyribonucleic acid (DNA). The incorporation of 5-FU also leads to inhibition of RNA and protein synthesis.

Read about Capecitabine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Capecitabine
L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01B Antimetabolites → L01BC Pyrimidine analogues
Discover more medicines within L01BC06

Medication package inserts

Below package inserts are available for further reading:

Title
Type
Country
Summary of Product Characteristics (SPC)
UK

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
BR
Câmara de Regulação do Mercado de Medicamentos
Identifier(s): 529206703112315, 529206704119313
CA
Health Products and Food Branch
Identifier(s): 02238453, 02238454
DE
Bundesinstitut für Arzneimittel und Medizinprodukte
Identifier(s): 00410399, 00410407, 01163661, 05385358, 05516079, 06568687, 06797672, 06849073, 10917538, 12367131, 15612513
ES
Centro de información online de medicamentos de la AEMPS
Identifier(s): 00163002
FI
Lääkealan turvallisuus- ja kehittämiskeskus
Identifier(s): 397752
FR
Base de données publique des médicaments
Identifier(s): 65918903, 69771849
HK
Department of Health Drug Office
Identifier(s): 46233, 46234
IT
Agenzia Italiana del Farmaco
Identifier(s): 035219017, 035219029
LT
Valstybinė vaistų kontrolės tarnyba
Identifier(s): 1003995, 1003996
NL
Z-Index G-Standaard, PRK
Identifier(s): 59358, 59366
PL
Rejestru Produktów Leczniczych
Identifier(s): 100103613, 100103620
SG
Health Sciences Authority
Identifier(s): 10677P, 10678P
TN
Direction de la Pharmacie et du Médicament
Identifier(s): 6993181H
US
FDA, National Drug Code
Identifier(s): 0004-1100, 0004-1101